NextCure (NXTC) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NXTC is expected to report earnings to fall 13.83% to -35 cents per share on February 27

Q4'24

Est.

$-0.35

Q3'24

Missed

by $0.06

Q2'24

Missed

by $0.17

Q1'24

Missed

by $0.17

Q4'23

Est.

$-0.52

The last earnings report on November 08 showed earnings per share of -40 cents, missing the estimate of -34 cents. With 54.80K shares outstanding, the current market capitalization sits at 27.17M.

View a ticker or compare two or three

Compare

NXTC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NXTC
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9000 Virginia Manor Road

Phone

+1 240 399-4900

Employees

Web

https://www.nextcure.com